According to Merck's latest financial reports the company's total liabilities are $69.04 B. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2023-12-31 | $69.04 B | 9.41% |
2022-12-31 | $63.10 B | -6.43% |
2021-12-31 | $67.43 B | 1.89% |
2020-12-31 | $66.18 B | 13.34% |
2019-12-31 | $58.39 B | 4.74% |
2018-12-31 | $55.75 B | 4.6% |
2017-12-31 | $53.30 B | -3.21% |
2016-12-31 | $55.06 B | -3.23% |
2015-12-31 | $56.91 B | 15.26% |
2014-12-31 | $49.37 B | -7.4% |
2013-12-31 | $53.31 B | 5.23% |
2012-12-31 | $50.66 B | 5.16% |
2011-12-31 | $48.18 B | -1.62% |
2010-12-31 | $48.97 B | -3.65% |
2009-12-31 | $50.82 B | 95.28% |
2008-12-31 | $26.02 B | -6.23% |
2007-12-31 | $27.75 B | 12.82% |
2006-12-31 | $24.60 B | 0.59% |
2005-12-31 | $24.46 B | 6.92% |
2004-12-31 | $22.87 B | 8.45% |
2003-12-31 | $21.09 B | -13.66% |
2002-12-31 | $24.43 B | 5.61% |
2001-12-31 | $23.13 B |
Company | Total liabilities | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $98.78 B | 43.08% | ๐บ๐ธ USA |
Novartis NVS | $53.19 B | -22.95% | ๐จ๐ญ Switzerland |
Pfizer PFE | $137.21 B | 98.74% | ๐บ๐ธ USA |
Abbott Laboratories ABT | $34.38 B | -50.19% | ๐บ๐ธ USA |
Eli Lilly LLY | $53.14 B | -23.03% | ๐บ๐ธ USA |
Amgen AMGN | $90.92 B | 31.69% | ๐บ๐ธ USA |
Sanofi SNY | $57.61 B | -16.55% | ๐ซ๐ท France |
Bristol-Myers Squibb BMY | $65.67 B | -4.88% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $58.82 B | -14.80% | ๐ฌ๐ง UK |
Teva Pharmaceutical Industries TEVA | $35.35 B | -48.79% | ๐ฎ๐ฑ Israel |